Juan R. Rodriguez-De La Haba
Cordoba, AN 14004, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 52 publications
Immunohistochemistry-Based Molecular Subtyping in Muscle-Invasive Bladder Cancer: Predicting Response to Neoadjuvant Chemotherapy.
Journal: Archivos espanoles de urologia
Published: July 13, 2026
SEOM‑GETTHI clinical guideline for the practical management of molecular platforms (update 2026).
Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
Published: July 10, 2026
Dynamic thymidine kinase activity independently captures treatment-specific biological response and is independently associated with outcomes in endocrine-resistant HR+ /HER2 - metastatic breast cancer: A translational analysis of the GEICAM/2013-02 PEARL trial.
Journal: European journal of cancer (Oxford, England : 1990)
Published: March 10, 2026
Correction: Hypertension as predictive factor for bevacizumab-containing first-line therapy in metastatic breast and colorectal cancer in BRECOL (GEICAM/2011-04) study.
Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
Published: November 25, 2025
Neoadjuvant Abemaciclib plus Letrozole vs. Chemotherapy in patients with HR+/HER2- Highly Proliferative Breast Cancer.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: June 30, 2025
Neoadjuvant Abemaciclib plus Letrozole Versus Chemotherapy in Patients with HR+/HER2- Highly Proliferative Breast Cancer.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: June 30, 2025
FOXC1 Expression Predicts Capecitabine Efficacy in Patients with Triple-Negative Breast Cancer from the GEICAM_CIBOMA Trial.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: January 27, 2025
Prioritizing breast cancer surgeries: insights from the KRONOS SCORE.
Journal: Frontiers in oncology
Published: July 15, 2024
Trastuzumab deruxtecan in patients with previously treated HER2-low advanced breast cancer and active brain metastases: the DEBBRAH trial.
Journal: ESMO open
Published: March 04, 2024
Hypertension as predictive factor for bevacizumab-containing first-line therapy in metastatic breast and colorectal cancer in BRECOL (GEICAM/2011-04) study.
Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
Published: October 27, 2023
Clinical significance of glycogen synthase kinase 3 (GSK-3) expression and tumor budding grade in colorectal cancer: Implications for targeted therapy.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: August 04, 2023
Last Updated: 09/26/2026